 Antibody Formation
"Antibody Formation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.
| Descriptor ID |
D000917
|
| MeSH Number(s) |
G12.070
|
| Concept/Terms |
Antibody Formation- Antibody Formation
- Formation, Antibody
- Antibody Response
- Antibody Responses
- Response, Antibody
- Responses, Antibody
- Antibody Production
- Production, Antibody
|
Below are MeSH descriptors whose meaning is more general than "Antibody Formation".
Below are MeSH descriptors whose meaning is more specific than "Antibody Formation".
This graph shows the total number of publications written about "Antibody Formation" by people in this website by year, and whether "Antibody Formation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 4 | 5 | | 1997 | 0 | 1 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 0 | 2 | 2 | | 2000 | 2 | 7 | 9 | | 2001 | 0 | 1 | 1 | | 2002 | 2 | 2 | 4 | | 2003 | 0 | 2 | 2 | | 2004 | 1 | 6 | 7 | | 2005 | 3 | 3 | 6 | | 2006 | 1 | 3 | 4 | | 2007 | 6 | 2 | 8 | | 2008 | 5 | 5 | 10 | | 2009 | 4 | 3 | 7 | | 2010 | 3 | 2 | 5 | | 2011 | 3 | 6 | 9 | | 2012 | 2 | 1 | 3 | | 2013 | 2 | 2 | 4 | | 2014 | 5 | 1 | 6 | | 2015 | 7 | 0 | 7 | | 2016 | 3 | 1 | 4 | | 2017 | 1 | 6 | 7 | | 2018 | 4 | 2 | 6 | | 2019 | 2 | 4 | 6 | | 2020 | 1 | 1 | 2 | | 2021 | 4 | 4 | 8 | | 2022 | 1 | 8 | 9 | | 2023 | 0 | 4 | 4 | | 2024 | 0 | 5 | 5 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibody Formation" by people in Profiles.
-
Crofts KF, Holbrook BC, Page CL, Hendrix CJ, Caudell D, Gillespie RA, D'Agostino RB, Moin SM, Sangesland M, Ornelles DA, Kanekiyo M, Alexander-Miller MA. A dual-adjuvanted HA stem nanoparticle vaccine elicits a multifunctional antibody response that is associated with protection in newborn monkeys. Cell Rep Med. 2026 May 19; 7(5):102746.
-
Valayer S, Alexandre M, Prague M, Beavogui AH, Doumbia S, Kieh M, Greenwood B, Leigh B, Poupelin M, Schwimmer C, Sow SO, Berry IM, Kuhn JH, Fusco D, Cauwelaert ND, Watson-Jones D, Thiébaut R, Lévy Y, Yazdanpanah Y, Richert L, Lhomme E. Evaluation of waning of IgG antibody responses after rVSV?G-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial. Emerg Microbes Infect. 2025 Dec; 14(1):0.
-
Davies LRL, Wang C, Steigler P, Bowman KA, Fischinger S, Hatherill M, Fisher M, Mbandi SK, Rodo M, Ottenhoff THM, Dockrell HM, Sutherland JS, Mayanja-Kizza H, Boom WH, Walzl G, Kaufmann SHE, Nemes E, Scriba TJ, Lauffenburger D, Alter G, Fortune SM. Age and sex influence antibody profiles associated with tuberculosis progression. Nat Microbiol. 2024 Jun; 9(6):1513-1525.
-
Jain S, Uritskiy G, Mahalingam M, Batra H, Chand S, Trinh HV, Beck C, Shin WH, Alsalmi W, Kijak G, Eller LA, Kim J, Kihara D, Tovanabutra S, Ferrari G, Robb ML, Rao M, Rao VB. A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1. Elife. 2024 Apr 15; 13.
-
Kim JS, Sun Y, Balte P, Cushman M, Boyle R, Tracy RP, Styer LM, Bell TD, Anderson MR, Allen NB, Schreiner PJ, Bowler RP, Schwartz DA, Lee JS, Xanthakis V, Doyle MF, Regan EA, Make BJ, Kanaya AM, Wenzel SE, Coresh J, Isasi CR, Raffield LM, Elkind MSV, Howard VJ, Ortega VE, Woodruff P, Cole SA, Henderson JM, Mantis NJ, Parker MM, Demmer RT, Oelsner EC. Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study. Nat Commun. 2024 Feb 19; 15(1):1492.
-
Ji W, Guthmiller J. Goldilocks Zone of Preexisting Immunity: Too Little or Too Much Suppresses Diverse Antibody Responses Against Influenza Viruses. J Infect Dis. 2024 02 14; 229(2):299-302.
-
Weinberg A, Scott Schmid D, Leung J, Johnson MJ, Miao C, Levin MJ. Predictors of 5-Year Persistence of Antibody Responses to Zoster Vaccines. J Infect Dis. 2023 11 11; 228(10):1367-1374.
-
Starling AP. Invited Perspective: Per- and Polyfluoroalkyl Substances and Impaired Antibody Response to Vaccination-Who Is Affected? Environ Health Perspect. 2023 08; 131(8):81304.
-
Gualano B, Sieczkowska SM, Lemes ÍR, da Silva RP, Pinto AJ, Mazzolani BC, Smaira FI, Aikawa NE, Kupa LVK, Pasoto SG, Medeiros-Ribeiro AC, Saad CGS, Yuk EFN, Silva CA, Swinton P, Hallal PC, Roschel H, Bonfa E. Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases. J Phys Act Health. 2023 04 01; 20(4):311-316.
-
Brewer RC, Lanz TV, Hale CR, Sepich-Poore GD, Martino C, Swafford AD, Carroll TS, Kongpachith S, Blum LK, Elliott SE, Blachere NE, Parveen S, Fak J, Yao V, Troyanskaya O, Frank MO, Bloom MS, Jahanbani S, Gomez AM, Iyer R, Ramadoss NS, Sharpe O, Chandrasekaran S, Kelmenson LB, Wang Q, Wong H, Torres HL, Wiesen M, Graves DT, Deane KD, Holers VM, Knight R, Darnell RB, Robinson WH, Orange DE. Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis. Sci Transl Med. 2023 02 22; 15(684):eabq8476.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|